Rejoyn™

Review by eFreeware

Most apps in the medical category are trackers, journals or mood diaries. Rejoyn is something different: it is described as a prescription digital therapeutic, authorized by the FDA for adults aged 22 and older who are already taking antidepressant medication for major depressive disorder. It is not a wellness app that you can simply decide to try one evening; a healthcare provider has to prescribe it first.

That single fact shapes everything else about it. The developer, Otsuka Precision Health, positions Rejoyn as an addition to clinician-managed outpatient care, not a replacement for medication or therapy. If your provider brings it up as part of your treatment, this review explains what the app involves and what it asks of you. If nobody has prescribed it, the download by itself will not get you very far.

The program runs for six weeks, with the developer suggesting you spend under two hours per week inside the app. That is a modest commitment compared with the weekly routine of a formal therapy program, and it is clearly designed to fit around whatever else your treatment already includes.

Brain training built around a six-week course

The core of Rejoyn is a set of brain-training exercises, paired with short lessons that teach skills drawn from therapy. The developer says the exercises and lessons were developed and studied by psychologists, psychiatrists and neuroscientists, and that they work through neuroplasticity, the brain's natural capacity to change. The comparison the developer offers is physical therapy, but aimed at the brain rather than a joint or muscle.

The structure is fixed rather than open-ended. Six weeks, under two hours a week, exercises and lessons delivered in sequence. I like that the scope is defined: you know when the program starts and when it ends, and there is no suggestion of an indefinite subscription-style routine. For someone who has struggled to stick with vague self-improvement habits, a bounded course with a clear finish line is easier to commit to.

It is worth being precise about what kind of evidence sits behind this. According to the developer, Rejoyn was tested in a phase 3 clinical trial and is a regulated medical device; taken alongside antidepressant medication, it reduced depression symptoms, and no side effects were tied to Rejoyn itself. Those are the developer's claims, and they are the reason the app requires a prescription rather than sitting in the general wellness aisle.

Reminders and the fifteen-minute window

Beyond the exercises and lessons, Rejoyn includes reminders to keep your sessions on schedule. The detail that stands out to me is how it handles interruptions: if a treatment session is broken off, the app prompts you to come back and finish the exercise within fifteen minutes so you do not lose the progress you have made.

That is a small feature, but it tells you something about how the program is meant to be used. Sessions are not something you dip in and out of while doing three other things; they are meant to be completed in one sitting, and the app nudges you back if life gets in the way. Anyone who has abandoned a course halfway through because a session was interrupted will recognize the problem this is trying to solve.

The most recent update, from September 2026, shortened the account setup process, made it easier to review consent choices about nurse support and about sharing updates with your healthcare provider, and included general technical fixes. None of that changes the treatment itself, but a shorter enrollment is a sensible thing to smooth out for an app that people arrive at through a prescription.

What Rejoyn asks of you before you start

The requirement is a prescription from a healthcare provider. The developer directs people to talk to their provider about Rejoyn, or to visit the app's website to learn about consulting with a provider online. Once a prescription is in place, you download the app and it walks you through setting up an account.

The download itself is free, there are no ads, and there are no in-app purchases. That is unusual for an app of this size and worth stating plainly, because it means the cost question sits with your provider and your coverage rather than with the app store.

The app is also explicit about its boundaries. It is not a standalone treatment, and it does not take the place of the medication you already take, including antidepressants; the developer says to keep following your existing treatment as directed. Rejoyn cannot warn your provider about anything. If your symptoms worsen, or you have thoughts of harming yourself or others, the guidance is to contact your provider, call 911 or go to the nearest emergency room. Those are serious instructions, and they make clear that the app is one component of care rather than a safety net.

Fitting the program into a real week

The realistic way to approach Rejoyn is as a scheduled part of your week, not something you open when you remember. Under two hours weekly over six weeks is roughly fifteen minutes a day, or a few longer blocks.

I would also treat the six-week span as the unit of judgment. Depression symptoms do not usually shift on a day-to-day basis, and a program built around neuroplasticity is not designed to produce a noticeable change after two sessions.

It helps to keep your provider in the loop as you go, since the app is meant to sit alongside clinician-managed care and the update makes it simpler to manage consent for sharing updates with them. If you are consulting a provider online specifically to obtain a prescription, it is worth sorting that out before you download, because the account setup assumes a prescription is already in hand.

A small, specific audience

Rejoyn is not trying to be a general mental health app. It is authorized for adults 22 and older with major depressive disorder who are on antidepressant medication and whose clinician is managing their outpatient care. The install count, over 100,000, and an average rating of 3.8 from 104 ratings suggest a modest but real user base rather than a mass-market audience, which fits the prescription model.

That is not a flaw in the design; it is the design.

The other thing to weigh is the scope of what the app does on its own. It delivers exercises, lessons and reminders, and it cannot alert your provider or substitute for your medication. Anyone expecting the app to carry the treatment by itself has the wrong picture of it.

A structured add-on for people already in treatment

If your healthcare provider has prescribed Rejoyn as an addition to your antidepressant medication, I would approach it as a six-week commitment with a defined weekly time budget and give it the full course before drawing conclusions.

Rejoyn is best understood as a tool that belongs inside a treatment plan your clinician is already overseeing, and it is for adults 22 and older in exactly that position that it makes the most sense.

What's new in version 1.11.0

We’ve updated Rejoyn to give you a faster, smoother enrollment experience by reducing the steps required to set up your account. We've streamlined consent choices, like nurse support and sharing updates with your healthcare provider, making them simpler to review and manage. This release also includes general technical enhancements and bug fixes to keep the app running smoothly.